Galmed Pharmaceuticals (GLMD)
(Delayed Data from NSDQ)
$0.31 USD
+0.01 (5.01%)
Updated Jul 25, 2024 03:44 PM ET
After-Market: $0.30 -0.01 (-2.60%) 4:32 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For GLMD
-
Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2023
-
Galmed Pharmaceuticals: Q2 Earnings Snapshot
-
Galmed Pharmaceuticals: Q1 Earnings Snapshot
-
Galmed Pharmaceuticals Reports First Quarter 2023 Financial Results and Recent Developments
-
Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2022
-
Galmed Pharmaceuticals: Q3 Earnings Snapshot
-
Galmed Pharmaceuticals: Q2 Earnings Snapshot
-
Galmed Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results
-
Galmed Pharmaceuticals (GLMD) Reports Q1 Loss, Misses Revenue Estimates
-
Galmed Pharmaceuticals (GLMD) Reports Q4 Loss, Misses Revenue Estimates
-
Galmed Pharmaceuticals (GLMD) Reports Q3 Loss, Tops Revenue Estimates
-
Galmed Pharmaceuticals (GLMD) Reports Q2 Loss